An Algorithm to Guide the Rational, Evidence-Based Use of Omalizumab in the Treatment of Chronic Urticaria.
Sign Up to like & getrecommendations! Published in 2018 at "Actas dermo-sifiliograficas"
DOI: 10.1016/j.ad.2018.08.002
Abstract: Omalizumab is a monoclonal anti-IgE antibody currently used in the treatment of chronic spontaneous urticaria (CSU) as a third-line option in cases refractory to treatment with the licensed dose of the first-line treatment or up… read more here.
Keywords: algorithm guide; use; treatment; rational evidence ... See more keywords